MHRA Class 4 Medicines Defect Information: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd)
Class 4 Medicines Defect Information: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd) Drug alert number: EL (24)A/340 Date issued: 27 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd) Company name: Chemidex Pharma Ltd [...]
The post MHRA Class 4 Medicines Defect Information: Ponstan 250mg Capsules & 500mg Tablets (Chemidex Pharma Ltd) appeared first on Community Pharmacy England.
Recent Comments